Patient-controlled transcutaneous electrical acupoint stimulation for chronic cancer pain and quality of life
Official title: Clinical Efficacy Evaluation of Patient-Controlled Transcutaneous Electrical Acupoint Stimulation in Improving the Quality of Life for Patients With Chronic Cancer Pain
Run by The Third Affiliated hospital of Zhejiang Chinese Medical University · NCT07308951 · Data updated 2026-11-12
This test will see if a patient-controlled electrical acupoint stimulation device (PC-TEAS) can improve quality of life for adults with chronic cancer-related pain.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 290 (estimated) |
| Sponsor | The Third Affiliated hospital of Zhejiang Chinese Medical University Academic / other |
| Locations | 1 site (Zhejiang, Hangzhou) |
| Status | Recruiting |
| Started | September 10, 2025 |
| Main results expected | October 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | December 30, 2025 |
| Trial ID | NCT07308951 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–80 with histologically or cytologically confirmed primary or metastatic malignancy, chronic cancer-related pain (average NRS ≥2 in the past week or regular opioid use), ECOG performance status ≤2, and life expectancy ≥3 months are appropriate candidates.
✕Probably not a fit
Patients whose pain is not caused by cancer, those with severe cardiopulmonary dysfunction or respiratory depression, individuals with implanted pacemakers or metallic implants at stimulation sites, or those unable to communicate or cooperate are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with histologically confirmed cancer and chronic cancer-related pain will receive either active PC-TEAS or a sham TEAS intervention while researchers track quality of life and pain-related outcomes over the treatment period. Outcomes include pain scores, analgesic consumption, emotional measures, spontaneous bowel movements, and adverse events to capture both efficacy and tolerability. The protocol supports home-based, patient-controlled use of the device to reflect real-world self-management. Findings aim to provide objective evidence on whether PC-TEAS can be a practical adjunct to usual care.
Why it matters
Potential benefit: If effective, PC-TEAS could offer a low-risk, home-administered option to reduce pain burden and improve quality of life while potentially lowering opioid needs.
How similar studies have gone: Related techniques such as TENS and acupoint electrical stimulation have produced mixed but sometimes positive results for pain and quality-of-life outcomes, while PC-TEAS specifically remains less extensively studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 and 80 years, regardless of gender; * Diagnosis of primary or metastatic malignant tumor confirmed by histopathology and/or cytology, consistent with the American Cancer Society criteria for malignancy; * Presence of cancer-related pain, defined as an average Numeric Rating Scale (NRS) score ≥ 2 over the preceding week or current regular use of opioid analgesics; * Life expectancy ≥ 3 months; * Eastern Cooperative Oncology Group Performance Status (ECOG-PS) score ≤ 2, stable vital signs, clear consciousness, intact pain perception, unimpaired communication, ability to cooperate with study procedures and complete assessments; * Provision of signed informed consent by the patient or their legal guardian after comprehensive explanation of the study; Exclusion Criteria: * Pain not attributable to cancer; * Severe cardiopulmonary dysfunction or respiratory depression; * Implantation of cardiac pacemaker or metallic implants at stimulation sites; * Local skin lesions or conditions unsuitable for TEAS at the acupoint sites; * Severe psychiatric disorders or significant cognitive impairment; * Concurrent participation in other clinical trials that may interfere with the outcome evaluation of this study; * Previous history of transcutaneous electrical acupoint stimulation (TEAS) or transcutaneous electrical nerve stimulation (TENS);
Where it's running
-
The Third Affiliated Hospital of Zhejiang Chinese Medicinal University
Zhejiang, Hangzhou, China Recruiting
Study contacts
- Study coordinator: Yi Liang, PhD
- Email: liangyiwww@126.com
- Phone: +86-571-86633328
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Virtual reality cognitive behavioral therapy for chronic cancer pain
This project tests whether a virtual reality program that delivers cognitive behavioral therapy can help adults with chronic cancer pain feel less pain than a two-dimensional tablet program.
-
Comparing symptoms in atrophic gastritis and dyspepsia
This project will test whether people with pathologically confirmed chronic atrophic gastritis have different types or severity of dyspepsia symptoms than similar patients without atrophic gastritis.
-
Electroacupuncture for cognitive problems after stroke
This trial will test whether electroacupuncture can improve thinking and memory in people who developed cognitive problems after a stroke.
-
Biomechanical evaluation of lumbar disc herniation treatment using lever positioning manipulation
This study is testing different ways of using a special manipulation technique to see if it can help people with lumbar disc herniation feel better.
-
Using electroacupuncture to enhance chemotherapy delivery for recurrent glioma
This study is testing if a special type of acupuncture can help deliver a chemotherapy drug more effectively to people with recurrent high-grade glioma who haven't had success with other treatments.
-
Acupuncture for treating primary insomnia related to liver and spleen issues
This study is testing if acupuncture can help young adults with insomnia caused by liver and spleen issues sleep better and feel healthier.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.